Recruiting Plaque Psoriasis Studies in Los Angeles
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis...
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity o...
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
The primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared to active control (ustekinumab) in children and adolescents aged 6 to \<18 years ...
A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
The purpose of the study is to evaluate the pharmacokinetic (PK) of certolizumab pegol (CZP) in study participants aged 6 to 17 years with moderate to severe chronic plaque psoriasis (PSO) in order to...
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
This is a multicenter, randomized, double-blinded, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of ORKA-001 in adult participants wit...
About Plaque Psoriasis Clinical Trials in Los Angeles
Plaque psoriasis is the most common form of psoriasis, characterized by raised, red patches covered with silvery-white scales. It can appear anywhere on the body and affects about 80% of people with psoriasis. Treatment includes topical therapies, phototherapy, and systemic medications including biologics.
There are currently 5 plaque psoriasis clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 3,638 participants. Research is being sponsored by Bristol-Myers Squibb, Eli Lilly and Company, UCB Biopharma SRL and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Plaque Psoriasis Clinical Trials in Los Angeles — FAQ
Are there plaque psoriasis clinical trials in Los Angeles?
Yes, there are 5 plaque psoriasis clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What plaque psoriasis treatments are being tested?
The 5 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for plaque psoriasis.
Data updated March 2, 2026 from ClinicalTrials.gov